TP53 and glioblastoma: In some cancers, such as glioblastoma multiforme (GBM), different genes involved in pathways involving TP53, phosphoinositide 3-kinase (PI3K), and RB1 are altered in different patients, and, importantly, these might be altered via different mechanisms [1], such as point mutations and CN changes.